• Kaja Kallas
  • Moussa Faki Mahamat
  • Adrian Zenz
  • Matthew Kroenig
  • Andriy Yermak
  • Vitaly Savelyev
  • Oleksandr Korniyenko
  • Dainius Kreivys
View All
IPSE'S AUTHORS LAST 24h
  • No New Authors inserted in the last 24 hours
Check all the Authors in the last 24h
IPSEs IN THE LAST 24H
  • Emmanuel Macron
    Emmanuel Macron “If the Russians were to break through the front lines, if there were a Ukrainian request [of sending ground troops to Ukraine], which is not the case today, we would legitimately have to ask ourselves this question.” 14 minutes ago
  • David Cameron
    David Cameron “We will give three billion pounds every year for as long as is necessary. We've just really emptied all we can in terms of giving equipment. The aid package was the largest from the UK so far. Some of that (equipment) is actually arriving in Ukraine today, while I'm here. Ukraine has a right to use the weapons provided by London to strike targets inside Russia, and that it was up to Kyiv whether to do so. Ukraine has that right. Just as Russia is striking inside Ukraine, you can quite understand why Ukraine feels the need to make sure it's defending itself.” 18 minutes ago
  • Ursula von der Leyen
    Ursula von der Leyen “I am following the situation in Georgia with great concern and condemn the violence on the streets of Tbilisi. The European Union has also clearly expressed its concerns regarding the law on foreign influence. The Georgian people want a European future for their country.” 23 hours ago
View All IPSEs inserted in the Last 24h

#antibodies

Page with all the IPSEs stored in the archive with the tag #antibodies linked to them.
The IPSEs are presented in chronological order based on when the IPSEs have been pronounced.

Naftali Bennett
Naftali Bennett

“A week into the fourth dose we know to a higher degree of certainty that the fourth dose is safe. The second piece of news: We know that a week after administration of a fourth dose, we see a five-fold increase in the number of antibodies in the vaccinated person. This most likely means a significant increase against infection and …hospitalization and (severe) symptoms.”

author
Israeli Prime Minister
04 Jan 2022 7 3
Read More
Gili Regev-Yochay
Gili Regev-Yochay

“We will examine the fourth dose's effect on the level of antibodies and morbidity and we will gauge its safety. We will understand whether it is worthwhile to administer a fourth shot, and to whom.”

author
Director of the study that analyzes the data of the Covid-19 fourth dose at the Sheba Medical Center
26 Dec 2021 2 3
Read More
Soumya Swaminathan
Soumya Swaminathan

“Everybody wants to know about the boosters, when it's needed, how often it's going to be needed and so on. There are many factors that can influence this. One is the type of vaccine. We know that each vaccine has a slightly different performance and longer follow up is telling us the efficacy of the vaccines, particularly in preventing severe disease but also in preventing infection. The other big variable of course is, the variants of the virus that we are seeing. And we've seen that different variants have different abilities to be neutralized by the antibodies, or be able to overcome the immune response, like Omicron seems to be doing because of the mutations it has it seems to be pretty good at evading immune responses. The third factor of course is the biology of the individual, the age of the person, how strong the immune system is, whether there are other underlying illnesses which impact the immune system. And therefore when we make recommendations for a course of vaccination, we have to take into consideration all of these factors. There is some data now to show that there is a slippage in the protection due to the different vaccines at about six months or so, particularly for protection from infection, less so for protection from disease; they are still performing at 80%. But with Omicron again, the initial data coming in obviously showing that Omicron is very successfully able to evade immune responses and therefore needs higher levels of antibodies. For now we believe that boosters may be needed for people who have weaker immune systems, the older individuals, the more vulnerable people and whether a third dose of the vaccine is going to be it, or whether they are going to be need for additional vaccines like influenza every year, every couple of years, it's too early to say and we need to really follow the science on that.”

author
World Health Organization’s (WHO) chief scientist
20 Dec 2021 5 3
Read More
Ugur Sahin
Ugur Sahin

“Our message is: Don't freak out, the plan remains the same: Speed up the administration of a third booster shot. Our belief [that the vaccines work against Omicron] is rooted in science: If a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe disease-the T-cells.”

author
Chief executive of Germany’s BioNTech
30 Nov 2021 6 4
Read More
Wendy Barclay
Wendy Barclay

“We can see the antibodies and we can see them declining and we know antibodies on their own are quite protective. On the balance of evidence, I would say it would look as if immunity declines away at the same rate as antibodies decline away, and that this is an indication of waning immunity.”

Bbc

author
Head of Department of Infectious Disease and Chair in Influenza Virology at Imperial College London
27 Oct 2020 4 2
Read More
Helen Ward
Helen Ward

“Immunity is waning quite rapidly, we're only three months after our first [round of tests] and we're already showing a 26% decline in antibodies.”

Bbc

author
Professor of Public Health at Imperial College London
27 Oct 2020 4 2
Read More
IPSEs by Context
May
MonTueWedThuFriSatSun
0102030405
06070809101112
13141516171819
20212223242526
2728293031
IPSEs by City
IPSEs by Author
IPSEs by Entity
IPSEs by Country
arrow